Association analysis of polymorphism in the promoter region of the α2a-adrenoceptor gene with schizophrenia and clozapine response

This publication has 24 references indexed in Scilit:

• Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention‐deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects
  Clinical Genetics, 1999
• Mspl identifies a biallelic polymorphism in the promoter region of the α_2A‐adrenergic receptor gene
  Clinical Genetics, 1997
• Idazoxan and Response to Typical Neuroleptics in Treatment-Resistant Schizophrenia
  The British Journal of Psychiatry, 1996
• Genetic variation of CNS receptors - a new perspective for pharmacogenetics
  Pharmacogenetics, 1995
• Clozapine-induced hypersalivation and the alpha2 adrenoceptor
  The British Journal of Psychiatry, 1995
• Putting the 'A' in atypical: does α2-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?
  Journal of Psychopharmacology, 1994
• Reserpine impairs spatial working memory performance in monkeys: reversal by the α2-adrenergic agonist clonidine
  Brain Research, 1993
• Pharmacological prospects for α2-adrenoceptor antagonist therapy
  Trends in Pharmacological Sciences, 1992
• Sub types of α2-adrenoceptors: Pharmacological and molecular biological evidence converg
  Trends in Pharmacological Sciences, 1988
• The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patients
  Acta Psychiatrica Scandinavica, 1987